These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 21359707)

  • 1. Immunological characterization.
    Redhead K
    Methods Mol Med; 1996; 4():223-9. PubMed ID: 21359707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing human biologicals in animal host resistance models.
    Burleson GR; Burleson FG
    J Immunotoxicol; 2008 Jan; 5(1):23-31. PubMed ID: 18382855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J; Egan W; Vicari G; Furesz J; Schild G
    Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity against Newcastle disease: the role of cell-mediated immunity.
    Reynolds DL; Maraqa AD
    Avian Dis; 2000; 44(1):145-54. PubMed ID: 10737655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.
    van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
    Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
    McCusker C; Somerville W; Grey V; Mazer B
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development.
    Thomas SJ; Hombach J; Barrett A
    Vaccine; 2009 Jan; 27(3):355-68. PubMed ID: 19022321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro methods for vaccine evaluation.
    Reitan LJ; Secombes CJ
    Dev Biol Stand; 1997; 90():293-301. PubMed ID: 9270857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.
    Igietseme JU; Eko FO; He Q; Black CM
    Expert Rev Vaccines; 2004 Feb; 3(1):23-34. PubMed ID: 14761241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the cell-mediated immune response in chickens by detection of chicken interferon-gamma in response to mitogen and recall Newcastle disease viral antigen stimulation.
    Lambrecht B; Gonze M; Meulemans G; van den Berg TP
    Avian Pathol; 2004 Jun; 33(3):343-50. PubMed ID: 15223565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
    Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E
    Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique characteristics of lacrimal glands as a part of mucosal immune network: high frequency of IgA-committed B-1 cells and NK1.1+ alphabeta T cells.
    Saitoh-Inagawa W; Hiroi T; Yanagita M; Iijima H; Uchio E; Ohno S; Aoki K; Kiyono H
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):138-44. PubMed ID: 10634613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoconjugate vaccines: future combinations.
    Paradiso PR; Lindberg AA
    Dev Biol Stand; 1996; 87():269-75. PubMed ID: 8854027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.
    Parreiras PM; Sirota LA; Wagner LD; Menzies SL; Arciniega JL
    Vaccine; 2009 Jul; 27(33):4537-42. PubMed ID: 19501205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
    Berger R; Luescher D; Just M
    Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.